Covid-19 Neutralizing Antibody Test
About SARS-CoV-2 virus
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the strain of coronavirus that causes coronavirus disease 2019 (COVID-19), the respiratory illness responsible for the COVID-19 pandemic. Those infected with the virus may be asymptomatic or develop common respiratory symptoms, including fever, cough and fatigue (other symptoms may include muscle pain, diarrhea, sore throat, loss of taste and smell, and abdominal pain). Severe patients may progress to acute respiratory distress syndrome (ARDS), septic shock, diffuse alveolar damage (DAD) and even death. The World Health Organization declared the outbreak a Public Health Emergency of International Concern on 30 January 2020, and a pandemic on 11 March 2020.
About Neutralising Antibody test
The SARS-CoV-2 Neutralising Antibody test is a unique test that could be used to boost current SARS-CoV-2 studies to determine infection rate, herd immunity, predicted humoral protection, and vaccine efficacy during clinical trials. The Neutralising Antibody test is currently in clinical trials phase and we expect to receive more information and publications in due course.